16.02.2016
- US drugmaker Eli Lilly has lost the latest round in an ongoing legal fight in the UK over patents relating to the administration of vitamins given alongside its blockbuster lung...
08.12.2015
- US drugmaker Eli Lilly is ending development of its injectable basal insulin peglispro (BIL), a potential treatment for type 1 and type 2 diabetes, to focus on other, more...
05.11.2015
- US drugmaker Eli Lilly plans to expand its research and development headquarters in Indianapolis, Indiana, to the tune of $70 million, adding floor space and a new disciplinary...
22.10.2015
- Six international drugmakers, led by GlaxoSmithKline (GSK) and including Johnson & Johnson, Biogen, Eli Lilly, Pfizer and Takeda, have joined forces with the UK Department of...
19.10.2015
- US drug maker Eli Lilly has discontinued clinical trials with evacetrapib, a potential blockbuster medicine it had hoped to recommend for treatment of high-risk atherosclerotic...
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
29.09.2015
- France’s Sanofi and US drugmaker Eli Lilly have resolved their patent dispute over insulin drugs. The settlement announced this week ends a US lawsuit brought by the French...
27.08.2015
- A court in Indiana, USA, has ruled in Eli Lilly’s favor in a long-running patent battle with Teva Pharmaceutical Industries relating to infringement of the vitamin regimen for its...
